Product Program year 2024 Source: CMS Open Payments

Prodigy

Device Neuromodulation

PDI 05414734405485

Open in the dashboard

General payments

$126,459

1,929 payments

Research payments

$0

0 payments

Through program year 2024, $126,459 in general payments and $0 in research payments were reported against Prodigy (Neuromodulation).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2024 General $30,459 153
2023 General $19,596 579
2022 General $76,404 1,197

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $126,459 1,929 payments
Top recipients General payments · program year 2024
  1. Pavli Demian Pain Medicine · Somerset, NJ $4,794 16% · 4 payments
  2. Ryan Nobles Interventional Pain Medicine · Mt Pleasant, SC $4,150 14% · 3 payments
  3. Alan Torrey Pain Medicine · Vicksburg, MS $3,600 12% · 3 payments
  4. Allegheny General Hospital Teaching hospital · PA $3,000 10% · 1 payment
  5. Richard Stayner Pain Medicine · Edina, MN $1,700 6% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Pain Medicine Physical Medicine & Rehabilitation $7,508 27% · 6 practitioners
  2. Interventional Pain Medicine Pain Medicine $7,196 26% · 18 practitioners
  3. Pain Medicine Anesthesiology $6,937 25% · 26 practitioners
  4. Physical Medicine & Rehabilitation $1,306 5% · 15 practitioners
  5. Neurological Surgery $1,227 4% · 4 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. New Jersey $6,264 21% · 2 recipients
  2. South Carolina $4,187 14% · 2 recipients
  3. Mississippi $3,860 13% · 8 recipients
  4. Pennsylvania $3,792 12% · 3 recipients
  5. Arizona $3,524 12% · 51 recipients

The top 5 of 20 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

1,929 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record